The goal of this project is to develop a noninvasive therapeutic strategy to protect US Service members from noise induced hearing loss (NIHL). To achieve this goal we will focus on testing the therapeutic potential of several molecular targets identified in our preliminary studies and determining their modes of action. NIHL is one of the most common occupational illnesses in the US affecting 12% of adolescents and 17% of adults. Currently, surgery cannot correct NIHL and there are no effective medicines available. NIHL is caused by damage to cells within the inner ear that detect sound and transmit the information to the brain. Exposure to intense levels of sound is common while serving in the military and can cause temporary or permanent hearing loss. Recently, it was unexpectedly found that many US service members acquire NIHL despite having normal hearing tests. This phenomenon, now called “hidden hearing loss”, represents a major health crisis for both the US Service members and the American public at large.
|Effective start/end date||9/1/19 → 8/31/22|
- U.S. Army Medical Research and Materiel Command (W81XWH1910627)